Dergi makalesi Açık Erişim
Senol, Halil; Ozgun-Acar, Ozden; Dag, Aydan; Eken, Ahmet; Guner, Huseyin; Aykut, Zaliha Gamze; Topcu, Gulacti; Sen, Alaattin
{
"DOI": "10.1021/acs.jnatprod.2c00798",
"abstract": "<p>Multiple sclerosis (MS) treatment has received much attention, yet there is still no certain cure. We herein investigate the therapeutic effect of olean-12-en-28-ol, 3 beta- pentacosanoate (OPCA) on a preclinical model of MS. First, OPCA was synthesized semisynthetically and characterized. Then, the mice with MOG35-55-induced experimental autoimmune/ allergic encephalomyelitis (EAE) were given OPCA along with a reference drug (FTY720). Biochemical, cellular, and molecular analyses were performed in serum and brain tissues to measure anti-inflammatory and neuroprotective responses. OPCA treat-ment protected EAE-induced changes in mouse brains maintaining blood-brain barrier integrity and preventing inflammation. Moreover, the protein and mRNA levels of MS-related genes such as HLD-DR1, CCL5, TNF-alpha, IL6, and TGFB1 were significantly reduced in OPCA-treated mouse brains. Notably, the expression of genes, including PLP, MBP, and MAG, involved in the development and structure of myelin was significantly elevated in OPCA-treated EAE. Furthermore, therapeutic OPCA effects included a substantial reduction in pro-inflammatory cytokines in the serum of treated EAE animals. Lastly, following OPCA treatment, the promoter regions for most inflammatory regulators were hypermethylated. These data support that OPCA is a valuable and appealing candidate for human MS treatment since OPCA not only normalizes the pro-and anti-inflammatory immunological bias but also stimulates remyelination in EAE.</p>",
"author": [
{
"family": "Senol",
"given": " Halil"
},
{
"family": "Ozgun-Acar",
"given": " Ozden"
},
{
"family": "Dag",
"given": " Aydan"
},
{
"family": "Eken",
"given": " Ahmet"
},
{
"family": "Guner",
"given": " Huseyin"
},
{
"family": "Aykut",
"given": " Zaliha Gamze"
},
{
"family": "Topcu",
"given": " Gulacti"
},
{
"family": "Sen",
"given": " Alaattin"
}
],
"container_title": "JOURNAL OF NATURAL PRODUCTS",
"id": "273276",
"issue": "1",
"issued": {
"date-parts": [
[
2023,
1,
1
]
]
},
"page": "16",
"title": "Synthesis and Comprehensive in Vivo Activity Profiling of Olean-12-en-28-ol, 3\u03b2-Pentacosanoate in Experimental Autoimmune Encephalomyelitis: A Natural Remyelinating and Anti-Inflammatory Agent",
"type": "article-journal",
"volume": "86"
}
| Görüntülenme | 38 |
| İndirme | 4 |
| Veri hacmi | 1.4 kB |
| Tekil görüntülenme | 37 |
| Tekil indirme | 4 |